68 / 100

Sponsors, grant funders & donors

A huge thank you to our sponsors, grant funders & donors for their invaluable support for RAREsummit21.

Thank you for partnering with us to improve the lives of those affected by rare conditions.


Cambridge Rare Disease Network - RAREsummit21 | Our Sponsors 1

Evolution Education Trust Helping raise awareness of the importance of the Theory of Evolution by funding impactful projects in the areas of therapeutics, education, conservation and fundamental research.

Prime Global Logo

Prime Global are experts in medical communications and market access, helping the world’s leading biotech, pharma, and healthcare companies to transform global health and patient outcomes, now and for future generations.



Healx AI-powered, patient-inspired treatments for rare diseases. Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.

Founded in Cambridge, UK, by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx’s AI-powered model of drug discovery is accelerating the pace, increasing the scale, and improving the chance of success of rare disease treatment development.
Read more


At LifeArc, we drive medical innovation through our own research and our work with a range of partners from industry, charities, universities, research organisations and others involved in improving lives for patients.

We have a 25-year legacy of collaborating with scientists on diagnostics and therapies, enhancing and protecting innovation and advancing promising research.
We focus on translation – progressing work from early lab-based findings through to development and a point where it can be used in patients. And by working in this way, we play a key role in developing new treatments, medicines, diagnostics, technologies or information resources, and in helping to turn research into practical products that benefit patients.
Read more

aparito logo RAREsummit21

Aparito creating technology solutions to revolutionise the patient experience of healthcare

Alexion AstraZeneca Rare Disease logo

Alexion AstraZeneca Rare Disease  is the group within AstraZeneca focused on rare diseases.

As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialisation of life-changing medicines.
Read more

sobi logo

Sobi  is dedicated to developing and delivering innovative treatments that improve the lives of people living with rare diseases. 



Ipsen is a global, mid-sized biopharmaceutical company focused on transformative medicines in Oncology, Rare Disease and Neuroscience. Patients and society are at the core of our mission.

Eastern AHSN (Academic Health Science Network) is funded by the NHS and the Office for Life Sciences to bring together academia, citizens, health services and industry to realise the value of innovations more quickly.

Dante Labs an established leader in genomic and diagnostic testing has been working diligently to create a new business unit to specifically meet the unique needs of undiagnosed and rare disease communities


Congenica logo

Congenica a digital health company enabling genomic medicine with the world leading Clinical Decision Support platform for research use for the rapid analysis and interpretation of genomic data

Amicus Therapeutics logo

Amicus Therapeutics a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases.

Kyowa Kirin logo

Kyowa Kirin  is a Japan-based Global Specialty Pharmaceutical Company, contributing to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the-art antibody technologies, in the core therapeutic areas of oncology, nephrology, central nervous system and immunology.

Kyowa Kirin logo

Founded in 2006, MRN is an innovative, market-leading Clinical Trial Support Organization in the field of international community focused clinical trial delivery. From inception we have delivered novel solutions using our specialized expertise and creative approaches. We support Drug Developers, Health Organizations and Investigators to accelerate the drug development process.